【结 构 式】 |
【分子编号】10188 【品名】2-Chloro-5-nitrobenzoic acid 【CA登记号】2516-96-3 |
【 分 子 式 】C7H4ClNO4 【 分 子 量 】201.5658 【元素组成】C 41.71% H 2% Cl 17.59% N 6.95% O 31.75% |
合成路线1
该中间体在本合成路线中的序号:(I)A more complete synthesis for LF-1695 has been reported: The reaction of 2-chloro-5-nitrobenzoic acid (I) with PCl5 in hot chlorobenzene gives the corresponding acyl chloride (II), which is condensed with chlorobenzene (III) by means of AlCl3, yielding 2,4'-dichloro-5-nitrobenzophenone (IV). The condensation of (IV) with 4-methylpiperidine (V) by means of K2CO3 at 150 C affords 4'-chloro-2-(4-methylpiperidin-1-yl)-5-nitrobenzophenone (VI), which is finally reduced with Fe or SnCl2 and HCl.
【1】 Ou, K.; Robin, J.; Bellamy, F.D.; Dodey, P.; Chazan, J.B.; Pascal, M.; Dutartre, P.; (Benzoylphenyl)piperidines: A new class of immunomodulators. J Med Chem 1991, 34, 5, 1545-52. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10188 | 2-Chloro-5-nitrobenzoic acid | 2516-96-3 | C7H4ClNO4 | 详情 | 详情 |
(II) | 10189 | 2-Chloro-5-nitrobenzoyl chloride | 25784-91-2 | C7H3Cl2NO3 | 详情 | 详情 |
(III) | 10190 | 1-Chlorobenzene | 108-90-7 | C6H5Cl | 详情 | 详情 |
(IV) | 10191 | (2-Chloro-5-nitrophenyl)(4-chlorophenyl)methanone | C13H7Cl2NO3 | 详情 | 详情 | |
(V) | 10192 | 4-Methylpiperidine; gamma-Pipecoline | 626-58-4 | C6H13N | 详情 | 详情 |
(VI) | 10193 | (4-Chlorophenyl)[2-(4-methylpiperidino)-5-nitrophenyl]methanone | C19H19ClN2O3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)The Ullmann condensation between 2-chloro-5-nitrobenzoic acid (I) and 2-amino-4-chlorobenzoic acid (II) afforded the diaryl amine (III). Cyclization of (III) by treatment with POCl3 in refluxing xylene yielded a mixture of the desired acridine (IV) and minor amounts of its regioisomer (V). The isomeric mixture of acids (IV) and (V) was activated as the respective mixed anhydrides with ethyl chloroformate and subsequently condensed with N,N-dimethylethylenediamine (VI) to produce the corresponding amides. The required isomer (VII) was easily isolated from the mixture owing to its insolubility in the reaction solvent. Finally, the title pyrazoloacridine compound was prepared by condensation of (VII) with 2-(dimethylamino)ethyl hydrazine in 2-ethoxyethanol at 120 C.
【1】 Antonini, I.; et al.; Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-Di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl) acridine-5-carboxamides. J Med Chem 2001, 44, 20, 3329. |
【2】 Matelli, S.; Polucci, P.; Antonini, I. (Università degli Studi di Camerino); Pyrazolo-acridine derivs. having antitumour activity. WO 9906405 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10188 | 2-Chloro-5-nitrobenzoic acid | 2516-96-3 | C7H4ClNO4 | 详情 | 详情 |
(II) | 52504 | 4-Chloro-2-aminobenzoic acid; 2-Amino-4-chlorobenzoic acid; 2-Carboxy-5-chloroaniline; 3-Amino-4-carboxy-1-chlorobenzene; 4-Chloroanthranilic acid | 89-77-0 | C7H6ClNO2 | 详情 | 详情 |
(III) | 52505 | C14H9ClN2O6 | 详情 | 详情 | ||
(IV) | 52506 | 1-chloro-7-nitro-9-oxo-9,10-dihydro-4-acridinecarboxylic acid | C14H7ClN2O5 | 详情 | 详情 | |
(V) | 52507 | 6-chloro-2-nitro-9-oxo-9,10-dihydro-4-acridinecarboxylic acid | C14H7ClN2O5 | 详情 | 详情 | |
(VI) | 14881 | N-(2-aminoethyl)-N,N-dimethylamine; N(1),N(1)-dimethyl-1,2-ethanediamine; 2-Dimethylaminoethylamine | 108-00-9 | C4H12N2 | 详情 | 详情 |
(VII) | 52508 | 1-chloro-N-[2-(dimethylamino)ethyl]-7-nitro-9-oxo-9,10-dihydro-4-acridinecarboxamide | C18H17ClN4O4 | 详情 | 详情 | |
(VIII) | 41186 | N-(2-hydrazinoethyl)-N,N-dimethylamine; 2-hydrazino-N,N-dimethyl-1-ethanamine | C4H13N3 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)Treatment of 2-chloro-5-nitrobenzoic acid (I) with PCl5 provides acid chloride (II), which is then condensed with anisole in the presence of AlCl3 to furnish the benzophenone (III). Alternatively, ketone (III) is prepared by Friedel-Crafts condensation of 2-chloro-5-nitrobenzoic acid (I) with anisole in hot polyphosphoric acid. Reduction of ketone (III) employing triethylsilane and trifluoromethanesulfonic acid gives rise to diphenylmethane derivative (IV)
【1】 Manning, R.E.; Tremont, S.J.; Glenn, K.C.; Keller, B.T. (Pharmacia Corp.); Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders. WO 0168096 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10188 | 2-Chloro-5-nitrobenzoic acid | 2516-96-3 | C7H4ClNO4 | 详情 | 详情 |
(II) | 10189 | 2-Chloro-5-nitrobenzoyl chloride | 25784-91-2 | C7H3Cl2NO3 | 详情 | 详情 |
(III) | 59706 | (2-chloro-5-nitrophenyl)(4-methoxyphenyl)methanone | C14H10ClNO4 | 详情 | 详情 | |
(IV) | 59707 | 4-(2-chloro-5-nitrobenzyl)phenyl methyl ether; 1-chloro-2-(4-methoxybenzyl)-4-nitrobenzene | C14H12ClNO3 | 详情 | 详情 |